Oligodendrocytes, the Forgotten Target of Gene Therapy
If the billions of oligodendrocytes (OLs) populating the central nervous system (CNS) of patients could express their feelings, they would undoubtedly tell gene therapists about their frustration with the other neural cell populations, neurons, microglia, or astrocytes, which have been the favorite...
Saved in:
Main Authors: | Yasemin Ozgür-Gunes, Catherine Le Stunff, Pierre Bougnères |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/13/23/1973 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
White Matter Injury in Central Nervous System Disorders
by: Zheng L, et al.
Published: (2025-01-01) -
Adeno-Associated Virus (AAV) Gene Therapy pada Hemofilia: A Systematic Review
by: Winda Angriani, et al.
Published: (2024-07-01) -
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
by: Liyan Zhang, et al.
Published: (2024-12-01) -
Cryopreservation of primary neonatal rat oligodendrocytes and recapitulation of in vitro oligodendrocyte characteristics
by: Hanki Kim, et al.
Published: (2025-01-01) -
CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production
by: Emily E. O’Driscoll, et al.
Published: (2025-03-01)